Mobidiag

company

About

Mobidiag is a Molecular diagnostic company developing and commercializing solutions for the detection of infectious diseases.

  • 101 - 250

Details

Last Funding Type
Debt Financing
Last Funding Money Raised
€4M
Industries
Biotechnology,Health Diagnostics,Life Science
Founded date
Jan 1, 2000
Number Of Employee
101 - 250
Operating Status
Active

Mobidiag is a commercial stage, fast-growing Finnish-French biotechnology company that develops and markets innovative molecular diagnostic solutions for gastrointestinal infections, antimicrobial resistance management, healthcare associated infections (HAIs), respiratory infections and sepsis. Based on well-established qPCR and microarray technologies, Mobidiag offers a broad range of tests and automated platforms. These include a comprehensive range of fast, reliable and cost-effective molecular diagnostic solutions for the detection of infectious diseases adapted to laboratories of all sizes. They allow detection of most clinically relevant bacteria, parasites, viruses and markers for antibiotic resistance.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
€29M $16.50M
Mobidiag has raised a total of €29M $16.50M in funding over 2 rounds. Their latest funding was raised on May 14, 2019 from a Debt Financing round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
May 14, 2019 Debt Financing €25M 1 European Investment Bank Detail
Nov 15, 2018 Debt Financing €4M 1 European Investment Bank Detail
Jul 18, 2016 Debt Financing $16.50M 1 European Investment Bank Detail

Investors

Number of Lead Investors
Number of Investors
3
1
Mobidiag is funded by 1 investors. European Investment Bank are the most recent investors.
Investor Name Lead Investor Funding Round
European Investment Bank Yes Debt Financing